Cinnamtannin A2, a Tetrameric Procyanidin, Increases GLP-1 and Insulin Secretion in Mice

被引:58
|
作者
Yamashita, Yoko [1 ]
Okabe, Masaaki [2 ]
Natsume, Midori [2 ]
Ashida, Hitoshi [1 ]
机构
[1] Kobe Univ, Dept Agrobiosci, Grad Sch Agr Sci, Nada Ku, Kobe, Hyogo 6578501, Japan
[2] Meiji Co Ltd, Food Sci Res Labs, Odawara, Kanagawa 2500862, Japan
关键词
procyanidin; cinnamtannin A2; glucagon like peptide-1 (GLP-1); insulin; hyperglycemia; GLUCAGON-LIKE PEPTIDE-1; CACAO LIQUOR; BIOAVAILABILITY; PHARMACOKINETICS; ANTHOCYANINS; POLYPHENOLS; ABSORPTION; FLAVANOLS; FRACTION; EXTRACT;
D O I
10.1271/bbb.130095
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Procyanidins are oligomers and polymers of flavan-3-ols consisting of (-)-epicatechin subunits. In this study, we isolated and purified dimeric, trimeric and tetrameric procyanidins from cacao liquor and investigated their influence on the "incretin effect" as compared to the monomer, (-)-epicatechin in mice. Cinnamtannin A2 specifically increased the glucagon-like peptide-1 (GLP-1) and insulin secretion levels in the plasma after 60 min administration. As evidence of the action of insulin, activation of insulin receptor and insulin receptor substrate-1 was observed in the soleus muscle. These results indicate that the intake of cinnamtannin A2 may improve hyperglycemia through an incretin-like effect, accompanied by activation of the insulin-signaling pathway.
引用
收藏
页码:888 / 891
页数:4
相关论文
共 50 条
  • [31] THE IMPACT OF GLP-1 RECEPTOR AGONISTS ON PATIENTS WITH DIABETES ON INSULIN THERAPY
    Gyorffy, Janelle B.
    Keithler, Andrea N.
    Wardian, Jana L.
    Zarzabal, Lee A.
    Rittel, Alexander
    True, Mark W.
    ENDOCRINE PRACTICE, 2019, 25 (09) : 935 - 942
  • [32] Procyanidin Dimers A1, A2, and B2 Are Absorbed without Conjugation or Methylation from the Small Intestine of Rats
    Appeldoorn, Maaike M.
    Vincken, Jean-Paul
    Gruppen, Harry
    Hollman, Peter C. H.
    JOURNAL OF NUTRITION, 2009, 139 (08): : 1469 - 1473
  • [33] In vitro effect of green tea and turmeric extracts on GLP-1 and CCK secretion: the effect of gastrointestinal digestion
    Planes-Munoz, David
    Lopez-Nicolas, Ruben
    Gonzalez-Bermudez, Carlos A.
    Ros-Berruezo, Gaspar
    Frontela-Saseta, Carmen
    FOOD & FUNCTION, 2018, 9 (10) : 5245 - 5250
  • [34] Acipimox Acutely Increases GLP-1 Concentrations in Overweight Subjects and Hypopituitary Patients
    Vestergaard, Esben Thyssen
    Hjelholt, Astrid Johanneson
    Kuhre, Rune E.
    Moller, Niels
    Larraufie, Pierre
    Gribble, Fiona M.
    Reimann, Frank
    Jessen, Niels
    Holst, Jens Juul
    Jorgensen, Jens Otto Lunde
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2019, 104 (07): : 2581 - 2592
  • [35] Gut HIF2α signaling is increased after VSG, and gut activation of HIF2α decreases weight, improves glucose, and increases GLP-1 secretion
    Evers, Simon S.
    Shao, Yikai
    Ramakrishnan, Sadeesh K.
    Shin, Jae Hoon
    Bozadjieva-Kramer, Nadejda
    Irmler, Martin
    Stemmer, Kerstin
    Sandoval, Darleen A.
    Shah, Yatrik M.
    Seeley, Randy J.
    CELL REPORTS, 2022, 38 (03):
  • [36] Peripheral activation of the Y2-receptor promotes secretion of GLP-1 and improves glucose tolerance
    Chandarana, Keval
    Gelegen, Cigdem
    Irvine, Elaine E.
    Choudhury, Agharul I.
    Amouyal, Chloe
    Andreelli, Fabrizio
    Withers, Dominic J.
    Batterham, Rachel L.
    MOLECULAR METABOLISM, 2013, 2 (03): : 142 - 152
  • [37] Effects of the soluble fiber complex PolyGlycopleX® (PGX®) on glycemic control, insulin secretion, and GLP-1 levels in Zucker diabetic rats
    Grover, Gary J.
    Koetzner, Lee
    Wicks, Joan
    Gahler, Roland J.
    Lyon, Michael R.
    Reimer, Raylene A.
    Wood, Simon
    LIFE SCIENCES, 2011, 88 (9-10) : 392 - 399
  • [38] Insulin vs GLP-1 analogues in poorly controlled Type 2 diabetic subjects on oral therapy: A meta-analysis
    Abdul-Ghani, M. A.
    Williams, K.
    Kanat, M.
    Altuntas, Y.
    DeFronzo, R. A.
    JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2013, 36 (03) : 168 - 173
  • [39] A prospective study of concomitant GLP-1 analogue and insulin use in type 2 diabetes in clinical practice
    van Velsen, E. F. S.
    Lamers, J.
    Blok, V.
    van Leendert, R. J. M.
    Kiewiet-Kemper, R. M.
    NETHERLANDS JOURNAL OF MEDICINE, 2014, 72 (10): : 523 - 527
  • [40] V1bR enhances glucose-stimulated insulin secretion by paracrine production of glucagon which activates GLP-1 receptor
    Yun, Ying
    Guo, Shimeng
    Xie, Xin
    CELL AND BIOSCIENCE, 2024, 14 (01):